Much attention has been given to the plight of minorities and persons of mixed race in need of a bone marrow transplant. This has led to increased efforts to recruit minority and mixed-race donors. There is strong evidence that members of racial minorities are less likely to find a match than those of European descent. Because the relevant sample sizes are small, direct estimation of the distribution of immunity types for mixed-race populations have not been available. We show how to estimate the distribution of HLA types for persons of mixed race indirectly, using simple principles of probability and the combinatorics of diploid reproduction. We show that recruitment of mixed race donors is cost-effective, but not for the expected reasons. While recruitment of mixed-race donors increases the welfare of patients with the same racial background, the benefits to the targeted recipients do not exceed the costs. However, when account is taken of the likelihood that a mixed-race registrant will be the only available match for a patient classified as being of a single race, the recruitment of mixed race donors turns out to be highly cost-effective.
Introduction
Patients with leukemia and other blood diseases stand a good chance of recovery and a return to normal life if they receive a stem cell transplant from a living donor. In the absence of a transplant, their survival prospects are grim. For a transplant to be successful, the immunity responses of the donor and recipient must be controlled by matching human leukocyte antigen (HLA) systems. Finding a match is often difficult because the distribution of HLA types in the human population is extremely diffuse. Type distributions differ between races. While the distributions of different races have some overlap, the probability that two randomly selected individuals will match is higher if they are of the same race. Approximately half of the population of European descent belong to types with frequency less than one in one hundred thousand, while twenty percent belong to types with a frequency of less than one in a million. The distribution of types for persons of Asian and African descent is even more diffuse.
Registries of potential stem cell donors have been established to deal with this problem. 1 The largest of these registries is the National Marrow Donor Program (NMDP) which includes more than 7 million registrants from the United States, Germany, Scandinavia, the Netherlands, and Israel. Because the number of persons of European ancestry in the NMDP registry is more than 10 times that of the other races, whites are much more likely to find a match than persons of other races. According to Bergstrom et al. (2009) , a Caucasian patient has a 92 percent chance of finding a match in the current registry, compared to only 62 percent for AfricanAmericans.
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As far as we know, there are no published estimates of matching probabilities for persons of mixed race. However, the plight of multiracial leukemia patients who are unable to find matching stem cell donors has received much attention in the news media. These accounts (Barbassa, 2009; Shay, 2010; Boodman, 2010; Taylor, 2010; Hansen, 2010) present wrenching stories of multi-racial individuals who have been unable to find a match and call for increased recruitment of minority and mixed-race individuals. The NMDP has emphasized recruitment of minority and mixed race donors and works in cooperation with organizations such as Match-1 New registrants contribute a saliva sample from which their HLA type is determined and state their willingness to donate to any patient for whom they are a match. Stem cells may be transferred from donors either by means of bone marrow transplants or by peripheral blood stem cell (PBSC) transfer. Both procedures involve temporary discomfort for the donor, but normally donors return to full health within two to three weeks.
2 See also, Beatty et al. (1995) , Hurley et al. (2003) , Bergstrom et al. (2009) , Schmidt et al. (2009) , Anasetti et al. (2010) , Dehn et al. (2010) , for estimates of matching probabilities for persons of a single race.
Maker, 3 Mixed Marrow, and Team Krissy 4 to increase mixed-race recruitment. These developments raise some important questions. First of all, what are the matching probabilities for people of mixed-race and how do they compare to those for individuals of single race? Second, is the current policy of targeted recruitment of mixed race individuals to registries socially efficient?
Estimating matching probabilities requires estimating the distribution of HLA types in each mixed race group. Because the relevant sample sizes are small, direct estimation of the distribution of types for mixed-race populations is not reliable. In this paper, we extend the analysis of Bergstrom et al. (2009) and show that the distribution of HLA types for persons of mixed race can be estimated using techniques similar to those developed in that paper. We do this by using existing estimates of the distribution of haplotypes in single-race populations and applying simple probability to the combinatorics of diploid reproduction. This is made possible by the fact that the alleles that determine HLA compatibility are located in close proximity on the same chromosome, and consequently genetic crossover is rare.
Our findings are surprising and somewhat contrary to the impression given by the popular media. Although biracial patients have lower matching probabilities than whites, their chances of finding a match in the existing registry are not very different from those of patients who have two parents of a single minority race. In fact, patients with one white parent and one minority parent are more likely to find a match in the registry than those who have two parents of the minority race. On average, the matching prospects for persons of multiple racial heritage are not as dire as media reports suggest. The genetics of HLA recombination is not like the chromatics of mixing paint. One does not inherit some HLA alleles from each predecessor in one's family tree. Regardless of the racial diversity of his or her ancestry, a person's HLA type is almost always determined by just two haplotypes, one of which is passed down from each parent. This means, roughly speaking, that in terms of stem cell matching, a person can only ever be biracial. The probability that someone of complex multi-racial ancestry will find a match is not lower than that of biracial individuals, but instead is an average of matching probabilities for the various biracial couples that could be constructed from pairs of her ancestors.
The next question that we confront is whether increased recruitment of mixed-race patients is socially optimal. While we find that biracial patients have a lower probability of finding a match in the registry than whites, this, in itself, 3 MatchMaker was founded in 2001 by the MAVIN foundation and has aided in the recruitment of over 10,000 mixed race donors.
Source: http://www.mavinfoundation.org/projects/matchmaker.html. 4 More information about Mixed Marrow and Team Krissy can be found at http://www.teamkrissy.com/index.htm and http://mixedmarrow.org/.
does not imply that adding a mixed race registrant is more likely to save a life than adding a white registrant, or that the expected benefits exceed the costs. The number of biracial patients seeking stem cell transplants is very small and hence the probability that an additional biracial registrant will provide a needed match for some biracial patient is also very small. But there is a surprising twist to the story. Patients documented as having the same multiracial heritage are not the only ones for whom an additional mixed race donor might be a unique match. In fact, a mixed-race donor is much more likely to be the only available match for a patient classified as of single race than for one clasified as being of the same mixed-race. Accounting for cross-race matches, we find that the present value of the benefits from adding someone of mixed race to the registry is five to seven times as great as the cost.
The paper is organized as follows. In Section 2 we outline the steps necessary to estimate the matching probabilities of people of mixed race and show how to compute the estimated number of lives saved by the addition of a new registrant of a given pure or mixed race combination. We then describe our method of converting these estimates into monetary benefits and costs. In Section 3 we present the results. These are motivated by relevant media reports that run contrary to our estimates. In Section 4 we provide a discussion of some of the issues that arise in defining racial categories. We also discuss the relevance of cord blood registries. A summary is provided in Section 5.
Methods

Genetic Background and Data Sources
The human leukocyte antigen (HLA) system is a complex of genes related to the immune system. The immune system uses the HLA genes to differentiate self cells and non-self cells, a task that is central to defense against disease. Cells that do not match the body's own HLA type are treated as invaders. In order for a stem cell transplant to be successful, the HLA genes of the donor and recipient must be a close match. Human HLA types are determined by the pairs of alleles found in a small number of genetic loci located on the same chromosome. The traditional medical standard for a suitable match for stem cell transplant has been that donor and recipient share the same six alleles in three specific loci, known as HLA-A, HLA-B, and HLA-DRB1. 5 The combination of six alleles that an individual has in these three loci is referred to as his or her phenotype.
The critical six alleles are inherited in the form of two strings of three, one from each parent. These three-allele strings are known as haplotypes. The haplotype that each parent passes to a child is randomly chosen from the parent's two haplotypes. Because the HLA alleles are located in close proximity on the same chromosome, recombination between these loci is very infrequent. Therefore, with rare exceptions, HLA haplotypes remain intact from generation to generation.
The largest available source of data on the distribution of HLA types is the NMDP registry. The NMDP records the self-reported race and the HLA type of each registrant. In a 1997 paper, Mori et al. (1997) used a sample of about 400,000 registrants who had been typed at the HLA-A, HLA-B, and DRB-1 loci in order to estimate the distribution of haplotypes in several racial subgroups of the U.S. population. More recently, Kollman et al. (2007) estimated haplotype using a larger sample of about two million registrants, including 1.2 million European-Americans, 250,000 Asian-Americans, 280,000 African-Americans, and 320,000 Hispanics.
Although the samples used in the Mori and Kollman studies are large, they are not nearly large enough to provide good direct estimates of the distribution of relatively rare types. Since there are tens of millions of possible HLA phenotypes, many of the rare types will not appear even in a sample of 2 million. But the mechanics of diploid genetics make it possible, under reasonable assumptions about mating patterns, to use the observed distribution of phenotypes to construct maximum-likelihood estimates of the distribution of HLA haplotypes for each race. Since the number of possible haplotypes at the three-locus level is "only" in the tens of thousands, the data available from the NMDP registry is sufficient to yield reasonably accurate estimates of haplotype distributions. The Mori and Kollman studies followed this strategy and published tables of estimated frequency distributions of haplotypes in each racial group.
Estimating Phenotype Distributions
We use the Kollman estimates (Kollman et al., 2007) of HLA haplotype frequencies within each race to construct corresponding estimates of the distribution of HLA phenotypes in the population for persons whose parents are of any two specified races. To accomplish this, we assume that matching is random with respect to HLA type. Thus the probability distribution of HLA types for persons of any specified race is independent of the HLA type and the race of their mating partner.
With this assumption, the combinatorics of sexual diploid reproduction allow us to find the distribution of HLA-types for biracial individuals. The phenotype of a person with one parent of race x and one of race y will be determined by six alleles-two in each of the loci, A, B, and DRB1. Let us denote these alleles as A 1 , A 2 , B 1 , B 2 , D 1 , and D 2 . Her six alleles could have been obtained in any one of 8 possible ways. For example, she could have inherited the three alleles A 1 , B 1 , and D 1 from the parent of race x (in the form of haplotype A 1 B 1 D 1 ) and the remaining alleles A 2 , B 2 , and D 2 (in the form of haplotype A 2 B 2 D 2 ) from the parent of race y. Alternatively, she could have inherited the haplotype A 2 B 1 D 1 from the parent of race x and the haplotype A 1 B 2 D 2 from the parent of race y. There are a total of 8 such possibilities. Since we have estimates of the haplotype distribution for each race, we can estimate the probability of each of these eight combinations. With this strategy, and the computational power of MatLab, we are able to calculate the probability of each of the roughly 25 million possible HLA phenotypes for persons of biracial parentage. 
Estimating Match Probabilities
Having estimated the distribution of phenotypes for persons of single race and biracial ancestry, we estimate the probability that a patient of specified ancestry will find a match in a registry of given size and racial composition. To make this estimate, we assume that the decision to join the registry and the need for a bone marrow transplant are both independent of a person's HLA type. Let R x be the number of persons of race or biracial ancestry x in the registry and let p x i be the fraction of the population of group x that is of HLA type i. The distribution of phenotypes in the registry among persons from group x is determined by R x independent draws, with probability p x i that each draw is of type i. The probability that no type i's are to be found among the R x registrants from group x is the probability that no type i's are selected in R x random draws from the population of race x, which is
A person of type i will find no match in the registry if there are no i's among registrants of any race. Therefore, if R is the vector listing the number of registrants from each group x, the probability that a person of type i has no match of any race in the registry is p
It follows that the probability that a person from group x has no match in the registry is
Effective Registry Sizes and Probability of a Match
The NMDP reports the numbers of potential donors who designate themselves as white, African-American, Asian-American, and Hispanic. They also report 250,000 registrants of "multiple race", but do not report the numbers of specific multi-race combinations. To provide such estimates, we make the simplifying assumptions that multi-race registrants are all biracial and that the proportions of each biracial combination in the registry are the same as those found in the U.S. Census. 7 The 2000 U.S. Census, asked respondents to specify their racial or mixed-racial ancestry. About 0.28 percent of the population were identified as mixed-race AfricanAmerican and white, 0.31 percent as mixed-race Asian and white, and 0.8 percent as white and "some other race" (Social Science Data Analysis Network, 2010).
Not every registrant is able or willing to donate when called upon to do so. The NMDP has provided statistics on the availability rate for donors of each race. We used these estimates of availability to estimate the size of the "effective" registry for each race: the expected number of persons of each race who are registered and will be available if called upon to donate. The number of effective registrants of each race are reported in Table 1 .
Using Equations 2 and 3 and our estimates of the effective size and composition of the NMDP registry, we estimate the probability that a randomly selected person of specified racial background will find a match in the NMDP registry. The resulting probabilities are reported in Table 2 of the Section 3.1.
Lives Saved by an Additional Registrant
In order to estimate the expected number of lives saved by an additional registrant of specified race, we first estimate the probability that this new registrant will provide a match for someone who did not previously have a match in the registry. Let us define G xy (R) as the increase in the probability that a person of race y will have a match in the registry that results from adding a registrant of race x, when the vector of registrants by race is R. Let p 0 i (R) be the probability that there is no potential 7 Because the research on HLA distributions does not treat race and ethnicity in the same way that the U.S. Census does, this required some assumptions. The data on HLA is divided into four categories: white, black, Asian, and Hispanic. The U.S. Census asks respondents to identify with one or more races (white, black, Asian, and Native American or Pacific Islander) and one ethnicity (Hispanic or non-Hispanic). We defined Hispanics as those who identified as "white" and "Hispanic" or "some other race" and "Hispanic." The later group was 30 times larger than "some other race" and "non-Hispanic," so we infer that many Hispanics must have been treating Hispanic as a race in answering the question. Following this logic, we defined mixed race white-Hispanic as those who identified as "white and some other race" and "Hispanic." Determination of the population of other groups was more straightforward. donor of type i in the registry. The probability that someone of race y is of type i and has no match in the registry is p y i p 0 i (R), and the probability that a new registrant of race x is of type i is p x i . Therefore the probability that a person of race y is of type i, has no match in the current registry, and will have a match if an additional person of race x is added to the registry is p 
Adding one more HLA type to the registry will result in an additional stem cell transplant only if a patient of that HLA type is in need of a transplant. To calculate the probability that adding a person of race x to the registry will result in an additional transplant to a person of race y during a given year, we must multiply G xy (R) by the number of persons of race y who will seek transplants during that year. We display the resulting estimates in Table 5 . Table 6 reports the probability that an additional registrant of specified ancestry will be the only available match for some patient in need of a transplant. Not every additional transplant saves a life. Possibly the patient would have survived without a transplant and possibly the patient will die despite receiving a transplant. In Bergstrom et al. (2009) we estimated the probability that providing a transplant will actually save a patient's life to be approximately 0.21. To determine the probability that adding an additional registrant will save a life during a single year, we must therefore multiply the probability found in Table 6 by 0.21.
Measuring Benefits and Costs
Since no one knows who will need a transplant in the future, and since few know whether their HLA type is common or rare, the stem cell registry is properly viewed as a public good that produces a small increase in survival probability for each person in the community. Economists have developed a tool, known as the "value of a statistical life" for calculating benefits of public projects that enhance public safety. The value of a statistical life (VSL) is an estimate of the rate at which individuals are willing to exchange money for small increments of survival probability. The VSL can be described as the total amount that members of a community would be willing to pay per expected life saved if the increments in survival probability for each individual are small. Discussions of the theoretical and empirical underpinnings of the VSL can be found in Bergstrom (1982) , Dehez and Drèze (1982) , Viscusi and Aldy (2003) , U.S. Environmental Protection Agency (2010), Johannesson et al. (1997) , Jones-Lee et al. (1985) and Blomquist (2004) .
In "Guidelines for Preparing Economic Analyses" (U.S. Environmental Protection Agency, 2010), the EPA recommends a VSL of 7.9 million 2008 dollars. This is consistent with the results of the most recent survey by Knieser et al. (2010) who report that estimates of the value of a statistical life are concentrated in the range $6 million to $10 million 2008 dollars. We follow the EPA recommendation, using a VSL of $7.9 million in our calculations.
Persons who join the bone marrow registry can remain in the registry until they reach age 61. The mean age of new registrants as reported by the NMDP is 35 years. We assume that a new registrant will, on average, remain in the registry for 25 years. Although medical technology is bound to change over the next 25 years and the number of persons annually seeking transplants may change dramatically, 8 we assume that the annual number of persons of each race seeking transplants will remain constant for the next 25 years and that the probability that a transplant saves the patient's life will remain constant as well. Following standard practice in economic benefit cost analysis, we discount future benefit flows by two percent per year. With these assumptions, we can calculate the expected present value of an additional effective registrant of each race. This quantity is found in the second column of Table 7 in Section 3.5.
The NMDP web site reports that the cost of tissue-typing an additional registrant was $52 in 2007. Personal communication with sources at the NMDP indicates that the total cost of obtaining sample material, tissue-typing, and maintaining a record of a new potential donor's contact information is approximately $105.
Since not all registrants are available when called upon, the registry must on average add more than one registrant to gain an effective registrant. The fractions of registrants who can be located, pass the physical examination, and who consent to make a donation are 0.57 for white registrants, 0.27 for African Americans, 0.35 for Asian Americans, and 0.34 for Hispanics.
Increasing the number of registrants increases the expected number of transplants and hence the expected total hospital and physician costs of performing these transplants. We estimate that total hospital and physician costs for a transplant are about $166,000. (This estimate is based on a survey of costs in 2001 by Redaelli et al. (2004) and converted to 2007 dollars.) Multiplying this cost by the probability that an additional registration results in an additional transplant, we find that the expected annual hospitalization costs resulting from adding a registrant range from about $7 for whites to about $28 for African American registrants. The third and fourth columns of Table 7 show our estimates of total costs attributable to adding an effective registrant of each racial group and the ratio of the present value of benefits to that of costs.
Results
We estimated the distribution of HLA types, the probabilities of finding a matching donor for persons of mixed race, and the cost-effectiveness of adding donors of mixed race. We find results that differ quite sharply from commonly-held beliefs reported in the news media.
Probability of Finding a Match
The widespread view that multi-racial patients have extremely poor chances of finding a match is expressed dramatically in a recent story in the Boston Globe (Barbassa, 2009).
"If Nick Glasgow were white, he would have a nearly 90 percent chance of finding a matching bone marrow donor who could cure his leukemia.
But because the 28-year-old bodybuilder is one-quarter Japanese, his doctor warned him the outlook was grim. Glasgow's background would make it almost impossible to find a match, which usually comes from a patient's own ethnic group.
The doctor "didn't say it was slim-to-none. He didn't say it would be hard. He said 'zero chance,' " Glasgow's mother . . . recalled." Table entries are the probabilities that a person of specified racial background has a 6/6 HLA-A,B,DRB1 match in the NMDP registry with composition described in Table 1 .
Our estimates indicate that prospects of finding a match for biracial patients are not so dire as such accounts suggest.
9 Table 2 reports the estimated probability that a randomly selected person of each race or biracial group will find at least one person of matching HLA type enrolled in the NMDP registry who is willing and able to donate. The table shows that matching probabilities are lower for biracial patients than for whites, but the chances for biracial patients are not very different from those of single minority race patients. In fact, patients with one white parent and one minority parent are, in all three cases, more likely to find a match in the registry than those who have two parents of the minority race.
Sources of Matching Donors
A recent Time Magazine story (Shay, 2010) states the commonly-held view that multiracial patients are largely dependent for matching donors on the registry of their own type.
"Though there are exceptions, the vast majority of successful matches take place between donors and patients of the same ethnic background."
This view is also reflected in the Cleveland Plain Dealer (Zeltner, 2009 ).
"Finding a bone marrow match depends largely on finding someone of the same race to donate, which can be particularly difficult for people of mixed race. . . . Mixed-race donors now make up only 3 percent of the 7 million potential adult marrow donors nationally." Notes: Table entries are probabilities that a person of specified race or mixed race has a 6/6 HLA-A,B,DRB1 match from a registry of the composition given in Table 1 .
If the only source of donors for multiracial patients were others of the same ancestry, their matching prospects would indeed be poor, as we see from the first column of Table 3 . But as the second column shows, biracial patients have a significant chance of finding a donor among white registrants. The third column reports the probability of finding at least one donor of some racial background.
It is true that someone of mixed race is more likely to match another person who combines the same racial ancestry than one who does not. But this effect is overwhelmed by the fact that the number of whites in the registry is about 150 times the number of white-Asian biracials and 190 times the numbers of white-African biracials. (See Table 1 .) Given that they have access to this larger pool, a majority of biracial patients will find matching donors in the registry.
Matching for Multiple-Race Patients
It might seem that finding a match for someone with a complex multiracial heritage would be more difficult than for someone who is simply biracial. This view is articulated in Time Magazine (Shay, 2010) .
"Athena Mari Asklipiadis, the founder of the California-based Mixed Marrow, one of the only outreach groups devoted to recruiting mixed race donors ...maintains the rates are lower-much lower. 'God forbid I need a match, because I'm a very rare combination,' Asklipiadis says of her mixed Japanese, Italian, Armenian, Egyptian and Greek background."
In the Boston Globe report (Barbassa, 2009 ) about Mr. Glasgow, the leukemia patient with one Japanese grandparent and three white grandparents, an NMDP spokesperson is quoted as saying: "The truth is, when people of different backgrounds marry and produce offspring, it creates more types that are harder to match. The probability just gets lower when you have people of mixed ancestral DNA."
Fortunately for the matching prospects of multiracial individuals, the genetics of HLA recombination is not as convoluted as one might expect. One does not inherit some HLA alleles from each ancestor. Since the alleles controlling HLA type are located near one another on the same chromosome, genetic crossover of these alleles is rare. Therefore the HLA type of an individual, regardless of the racial diversity of her ancestry is almost always determined by just two haplotypes, one of which is passed down from each parent. It follows that the probability of finding a match for someone of complex multi-racial ancestry is not lower than that of biracial individuals, but instead is an average of matching probabilities over the various biracial couples that could be constructed from pairs of her ancestors.
Consider an individual whose four grandparents are of four different single races. The probability distribution of this person's type will be a mixture distribution with a weight of one-fourth for each of the possible biracial pairs consisting of one paternal and one maternal grandparent. 10 The probability of having a match in the registry will be the arithmetic mean of the probabilities of finding a match for persons of these four possible biracial combinations. Suppose, for example, that a patient has one biracial parent of Asian-American and white descent and one biracial parent of African-American and Hispanic-American descent. Using the estimates of matching probabilities for biracial populations found in Table 2 , we calculate that the probability that she will have a match in the NMDP registry is It is straightforward to extend this method recursively to find matching probabilities for individuals who have one or more multi-racial grandparents.
Effectiveness of New Mixed-Race Registrants
News stories (Shay, 2010; Boodman, 2010; Taylor, 2010; Hansen, 2010) about multiracial patients seeking donations argue that because multiracial patients have much difficulty in finding matches, there is an urgent need for more multiracial donors in the stem cell registry. While it is true that biracial patients have a lower probability of finding a match in the registry than whites, this, in itself, does not imply that adding a mixed race registrant is more likely to save a life than adding a white registrant. As Table 4 shows, the number of biracial patients seeking stem cell transplants is one or two orders of magnitude smaller than it is for single races. Consequently the probability that an additional biracial registrant will be a match for some biracial patient in need of a transplant is also small. Despite the small number of mixed race patients, mixed-race registrants are among the most likely to be the only available match for some patient in need of a transplant. The reason is that patients with the same background are not the only ones for whom an additional mixed race donor might be a unique match. In fact, the probability is much larger that a mixed-race donor is the only available match for a patient of single race than for a mixed-race patient. Each entry in Table 5 is an estimate of the probability that an additional registrant of the racial group indicated for the entry's row will a match for a previously unmatched person of the racial group indicated for the entry's column. Notes: The number of NMDP-facilitated transplants by single race was obtained from Resources and Administration (2009) . To impute the number of transplants for mixed race groups, we started with our estimates of the distribution of races and mixed-races from the 2000 US Census as described in footnote 7. We then used estimates by Qian Qian (2004) of the ratio in which persons with one white and one minority parent self-identify by single race and assumed that biracial persons with two minority parents are equally likely to identify with each race. This enabled us to impute what proportion of each single race group "actually" belonged to each mixed race group. Finally, the number of potential transplants was inferred by dividing the number of performed transplants by the matching probability for each group reported in Table  2 . Notes: Equation 4 was used to calculate the effect of adding a registrant of the row race on the probability that a patient of the column race will find a match. The result was multiplied by the number of patients of the column race seeking transplants in 2008, as given in Table 4 .
The diagonal elements of the matrix in Table 5 show the probability that a new registrant of specified racial background will be the only available match for some patient of the same background. We see that the diagonal entries for persons of single race are much larger than the diagonal entries for biracial individuals. This means that if the only recipients of donations from biracial donors were of the same biracial background, adding biracial donors to the registry would be less effective than adding single-race registrants of any race.
Reading down the column for white recipients, we see something remarkable. The largest entries in this column are in the rows corresponding to biracial groups. This means that if one were to select a single registrant to add to the current registry with the objective of improving the matching prospects of white patients, adding a biracial registrant would be more effective than adding a white registrant. As the table shows, the best option for white patients would be to add someone who had one white and one African-American parent, while the second-best would be to add someone with one white and one Asian-American parent. Even a biracial registrant with no white parents is more likely to provide a unique match for a previously unmatched white patient than an additional white registrant.
Because the number of whites in the registry is very large, the types not currently represented in the registry are rare in the white population. As discussed in Section 4.1, these rare types include individuals who are culturally classified as white, but who carry haplotypes passed down from one or more nonwhite ancestors. For such persons, the biracial population is the most promising source of potential matches. Table 6 summarizes these results. The first column of this table shows the probability that adding a registrant of specified single race or biracial group will result in a match for a patient with the same ancestry who has no other match. These entries are smaller for biracial individuals than for persons of single race. The second column records the probability that an additional registrant will produce a match for a patient of some race who would otherwise have no match. This column shows that new mixed race registrants are more likely to provide a match for some previously unmatched patient than are new white registrants, though less likely to do so than new African-American registrants. Notes: The first column repeats the diagonal entries from Table 5 while the second column is the row sum from that table.
Comparing Benefits and Costs
Employing the detailed methods discussed in Section 2.6, we compare the expected present value to the expected cost of adding a new potential donor to the NMDP registry. Table 7 displays the resulting comparisons for new registrants by racial background. According to our estimates, the expected value of adding a new registrant to the stem cell registry exceeds the cost for registrants of all single-race and biracial backgrounds. The ratio of benefits to costs is highest for African-American registrants, intermediate for other minorities and those of mixed race and lowest for white registrants.
Discussion
Racial Categories and HLA Matching
The four major racial categories into which NMDP registrants are partitioned are coarse and quite arbitrary. Since the recorded race of a registrant is self-declared, it does not necessarily correspond to genetic inheritance. Statistics show, however, that the distribution of HLA types differs markedly across these self-identified categories. For example, our estimates suggest that the probability that a random self-reported white will match another randomly selected white is 34 times that of matching a random Asian-American, 16 times that of matching a random AfricanAmerican, and 6 times that of matching a random Hispanic.
Our computations are based on the Kollman et al. (2007) estimates of the distribution of haplotypes within each race, which depend on two critical assumptions about marriage patterns. The first is that racial groups are endogamous (marriage occurs almost entirely within races). The second is that, conditional on marrying within their group, the probability that two people marry is independent of their HLA types.
Since marriage patterns are more likely to be determined by socially perceived race than by genetic characteristics, the use of self-declared race to determine categories seems appropriate for the model estimated here. Jacobs and Labov (2002) collected data on all married heads of households and their spouses from a 1 percent sample of the 1990 U.S. Census. They found that almost 98 percent of marriages of whites and 96 percent of marriages of African-Americans were endogamous. The Jacobs and Labov study shows that approximately 85 percent of Asian-Americans are married to other Asian-Americans and 77 percent of Hispanics are married to other Hispanics.
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Although current rates of intermarriage between African-Americans and whites are low, African-Americans carry a significant amount of genetic material obtained from white ancestors. As Kittles et al. (2007) observe, "The vast majority of contemporary African Americans are descendants of enslaved Africans kidnapped and transported to America during the transatlantic slave trade from 1619 to 1850." During the period of slavery, there was substantial mixing of the white and African-American gene pool. Kittles et al report that it is estimated that there were about 4.5 million people of African descent in the U.S. in 1860, of which 600,000 were of mixed ancestry.
Geneticists have developed methods for using genetic markers to estimate admixture proportions, which are the proportions of genetic material in a single population that is inherited from members of two or more distinct ancestral populations. (See Shriver et al. (2003) for a discussion of these methods and further references.) Several studies have estimated admixture proportions from samples of African-Americans. These studies indicate that the percentage of European admixture in the African-American population differs substantially by region, ranging from 3.5 percent in the Gullah sea island community of South Carolina, 10 percent 11 Jacobs and Labov report rates of out-marriage for each of several Asian nationalities. We weighted these rates by the number of marriages of each type to find an average rate of out-marriage.
12 According to Jacobs and Labov, among Hispanics, the marriages of 82 percent of MexicanAmericans, 76 percent of Cuban-Americans and 66 percent of Puerto Ricans were endogamous within these subgroups.
in the rural South, about 20 percent in the industrial North, and 22-35 percent on the West Coast; see Kittles et al. (2007) (Figure 2) and Parra et al. (1998) . (The admixture of African-American genetic material in the U.S. white population appears to be much smaller. Shriver et al. (2003) estimates a mean admixture rate of less than one percent.)
The genetic composition of the current population depends on the marriage patterns of their parents' generation. The current population of Asian-Americans and of Hispanics are children of more endogamous populations than is indicated by current marriage patterns. About 2/3 of the existing population of Asian-Americans were born in Asia and their ancestors for many generations would have had little exposure to non-Asians. About one third of the Hispanic population are immigrants from regions where the population is almost entirely Hispanic.
While the assumption that Asian-Americans marry endogamously is not wildly inaccurate, the assumption that marriage among Asian-Americans is random with respect to HLA type is clearly violated. The marriage patterns of the parents of the current generation of Asian-Americans were far from random. Two-thirds of this population are immigrants, coming from several distinct Asian populations that have been geographically separated for many generations. Table 8 reports the distribution of the Asian-American population by national origin. Even after reaching the United States, Asian-Americans have been far more likely to marry within their own nationality than outside of it. Jacobs and Labov (2002) find that about 80% of Asian-American marriages are between two people of the same national origin. Since the distribution of HLA types differs significantly between Asian nationalities (Bodmer et al., 1987) , it follows that the HLA types of Asian American marriage partners are not random draws from the distribution of HLA types in the full Asian American population.
The Hispanic population of the United States includes distinct sub-populations that differ in ethnic makeup and have had little contact with each other for many generations. About 66 percent of the Hispanic population of the United States is of Mexican extraction, 13 percent come from Central and South America, 9 percent are Puerto Rican, and 4 percent are of Cuban extraction. Genetic admixture studies of Hispanics in the U.S. reveal that Mexican-Americans on average have 30-40 percent Native American ancestry, while immigrants from the Spanish Caribbean have African genetic contributions that range from 20-40 percent and contributions of about 18 percent from the native American Arawaks and Caribs; see Kittles et al. (2007) and Klimentidis et al. (2008) .
Estimates of matching probabilities could be improved with the use of HLA haplotype distributions for more finely distinguished population groups. Many published estimates of frequency distributions of common HLA haplotype distributions for narrowly-defined national and regional populations throughout the world are available. Examples include Schmidt et al. (2010) , Bodmer et al. (1987) , Rendine et al. (1998) , Shaw et al. (1999), and Charron (1997) . These estimates are usually based on samples of a few hundred individuals and hence provide reliable information only about the distributions of the most common haplotypes. It would be interesting to apply statistical methods along with estimates of the most common haplotypes to disentangle the distribution of haplotypes of highly endogamous subpopulations within the broad racial groups for which we have aggregate data. 
Cord Blood
In recent years, umbilical cord blood collected from newborn infants and cryogenically stored has become an important alternative source for stem cell transplants. In 2010, the NMDP had 145,000 units of cord blood in storage, as compared to 9 million registered potential adult donors, and about 1/5 of all stem cells arranged by the NMDP were from cord blood NMDP (2010). As with adult stem cells, the success probability of cord blood transplants depends on the matching of the immune systems of donor and patient, though with cord blood, mismatches of one or two alleles are thought to be less dangerous than they are for adult stem cells. The method used in this paper can be applied to finding the probabilities of full and partial matches in the cord blood registry. A more thorough benefit-cost analysis would need to explore optimal strategies for cord blood storage and to account for the fact that the adult stem cell reg-istry and the bone marrow registry are partial substitutes. The logistics of the adult stem cell registry are very different from that of the cord blood banks. The adult registry stores only information, while the cord blood banks must store frozen cord blood. Obtaining, testing, and processing a unit of cord blood costs about $2000 and there is an annual cost of about $50 for storage. Most cord blood units are not large enough to serve a full grown adult patient (There is an emerging technology for using cord blood from two infants for patients who cannot find a sufficiently large single unit.) The cost of registering and testing a potential donor for the adult registry is about $100. When a transplant occurs, retrieval of a cord blood unit is cheaper and quicker than obtaining an adult donation, which involves a hospital visit for the donor and related expenses.
In a future paper we intend to explore optimal strategies for maintaining a cord blood registry and the optimal mix of banked cord blood units and registered potential adult donors.
Summary
We estimated the probability distribution of HLA types for persons of mixed race and calculated the probability that a patient of specified racial background will find a matching donor in the existing stem cell registry. If the only source of matches for multi-racial individuals were donors of the same multi-racial ancestry, their chances of finding matching donors would be small. But biracial individuals stand a good chance of finding a match in the registry of white donors. Just as patients of mixed race are more likely to find a match in the pool of white donors than in the much smaller pool of donors of their own background, those of mixed race who join the stem cell registry are more likely to be the only available match for a white patient than for one of their own race.
Our estimates support the view that recruitment of mixed-race registrants deserves high priority, not so much because of the plight of mixed race patients, as because mixed race individuals are likely to match previously unmatched patients classified as being of single race.
Remarkably, it turns out that adding a biracial registrant (of any biracial combination) is more likely to produce a match for a previously unmatched white patient than adding a white registrant. According to our estimates, the present value of benefits from adding registrants of all races and biracial combinations exceed the costs. The net benefit from additional African-American registrants is highest, followed by the net benefits from biracial individuals and then by the net benefits from other single-race minorities. Benefits from adding a white registrant are lower, but still about four times as large as costs.
